SCHEMBL14060041

SCHEMBL14060041

Cc1[nH]c(-c2ccsc2)nc1-c1ccc2ccccc2c1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 2/20 0.47
TEK Q02763 3/20 0.43
ALOX5 P09917 1/20 0.43
NPY5R Q15761 5/20 0.42
HPGDS O60760 1/20 0.42
SMPD3 Q9NY59 2/20 0.40
MAPK8 P45983 1/20 0.40
MAPK9 P45984 1/20 0.40
MAPK10 P53779 1/20 0.40
PDGFRB P09619 1/20 0.40
PDGFRA P16234 1/20 0.40
NQO2 P16083 1/20 0.40
IKBKB O14920 1/20 0.39
CSNK1D P48730 1/20 0.37
MAPK11 Q15759 1/20 0.37
BACE1 P56817 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31305507 1.00 MAPK14 (0.47) MAPK14TEKALOX5NPY5RHPGDS
SCHEMBL14060013 0.84 NPY5R (0.54) MAPK14NPY5RHPGDSSMPD3MAPK9
SCHEMBL14333861 0.84 NPY5R (0.44) NPY5RHPGDSSMPD3
SCHEMBL2944563 0.83 NPY5R (0.59) MAPK14TEKALOX5NPY5RHPGDS
SCHEMBL31305477 0.83 NPY5R (0.59) MAPK14TEKALOX5NPY5RHPGDS
SCHEMBL31305473 0.83 MAPK14 (0.58) MAPK14TEKALOX5MAPK9MAPK11
SCHEMBL14060415 0.83 MAPK14 (0.58) MAPK14TEKALOX5MAPK9MAPK11
SCHEMBL14334220 0.81 NPY5R (0.57) MAPK14NPY5RHPGDSSMPD3MAPK9
SCHEMBL14060066 0.81 RAF1 (0.45) MAPK14NPY5RHPGDSSMPD3PDGFRB
SCHEMBL14059771 0.80 NPY5R (0.63) MAPK14ALOX5NPY5RHPGDSSMPD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4506488-A1 SURFACE TREATMENT AGENT FOR COPPER OR COPPER ALLOY Shikoku Chemicals Corporation (JP) 2025-02-12 EP disclosed
WO-2023190263-A1 SURFACE TREATMENT AGENT FOR COPPER OR COPPER ALLOY 四国化成工業株式会社 2023-10-05 WO disclosed
US-10398028-B2 Surface treating composition for copper and copper alloy and utilization thereof SHIKOKU CHEMICALS CORPORATION (JP) 2019-08-27 US disclosed
US-20170064823-A1 SURFACE TREATING COMPOSITION FOR COPPER AND COPPER ALLOY AND UTILIZATION THEREOF SHIKOKU CHEMICALS CORPORATION (JP) 2017-03-02 US disclosed
US-9532493-B2 Surface treating composition for copper and copper alloy and utilization thereof SHIKOKU CHEMICALS CORPORATION (JP) 2016-12-27 US disclosed
CN-103547706-B Surface treatment composition for copper and copper alloy and use thereof 四国化成工业株式会社 2016-09-28 CN disclosed
EP-2714962-B1 SURFACE TREATING COMPOSITION FOR COPPER AND COPPER ALLOY AND UTILIZATION THEREOF SHIKOKU CHEM (JP) 2015-07-08 EP disclosed
US-20140097231-A1 SURFACE TREATING COMPOSITION FOR COPPER AND COPPER ALLOY AND UTILIZATION THEREOF SHIKOKU CHEMICALS CORPORATION (JP) 2014-04-10 US disclosed
CN-103547706-A Surface treatment composition for copper and copper alloy and use thereof SHIKOKU CHEM 2014-01-29 CN disclosed
WO-2012161341-A1 SURFACE TREATING COMPOSITION FOR COPPER AND COPPER ALLOY AND UTILIZATION THEREOF SHIKOKU CHEMICALS CORPORATION (JP) 2012-11-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10398028-B2 Surface treating composition for copper and copper alloy and utilization thereof SOD1, SOD3, AOC3 MAPK14 882/4885TEK 4593/4885ALOX5 3363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.